Zbinden G.Neglect of function and obsession with structure in toxicity testing. Proceedings of the 9th International Congress Pharmacology, vol. I, pp. 43-49. London: Macmillan Press Ltd, 1984.
2.
Theus R. & Zbinden G.Toxicological assessment of the hemostatic system, regulatory requirements, and industry practice. Regulatory Toxicology and Pharmacology1984; 4: 74-95.
3.
Barnes JM & Denz FAExperimental methods used in determining chronic toxicity. Pharmacology Review1954; 6: 191-242.
4.
Zbinden G., Elsner J. & Boelsterli UAToxicological screening. Regulatory Toxicology and Pharmacology1984; 4: 275-86.
5.
Young DMPathologic effects of adriamycin (NSC-123 127) in experimental systems. Cancer Chemotherapy Reports1975; 6: 159-75.
6.
Zbinden G., Bachmann E. & Holderegger C.Model systems for cardiotoxic effects of anthracyclines . Antibiotics and Chemotherapy1978; 23: 255-70.
7.
Sparano BM, Gordon G., Hall C., latropoulos MJ & Noble JFSafety assessment of a new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology Cancer Treatment Reports1982; 66: 1145-58.
8.
Zbinden G. & Beilstein AAComparison of cardiotoxicity of two anthracenediones and doxorubicin in rats . Toxicology Letters1982; 11: 289-97.
9.
Bachmann E., Weber E. & Zbinden G.Effects of mitoxantrone on energy metabolism of the heart. Cancer Treatment Reports1987; in press.
10.
Green AF, Amstrong JM, Farmer JM, et al. Autonomic pharmacology: report of the main working group. Pharmacology and Therapeutics1979; 5: 9-48.
11.
Elsner J.The use of computers in neurobehavioral studies. In Pharmacodependence and Neurobehavioral Toxicology: quo vadis? Symposium Quo Vadis? Sanofi
12.
Group, June 1-2, 1983, Montpellier, France. 12 Elsner J. Testing strategies in behavioural teratology: III. Microanalysis of behavior. Neurobehavioral Toxicology and Teratology1986; 8: 573-84.
13.
Fent K., Mayer E. & Zbinden G.Toxicological screening: urine cell counts as marker of renal toxicity. Experientia1987; in press.
